Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 30 n° 318

Colorectal Cancer Screening Programs

Posted by fidest press agency su venerdì, 12 ottobre 2018

Clinical Genomics, the manufacturer of the InSure ONE fecal immunochemical test (FIT), is pleased to discuss the new American Cancer Society (ACS) Colorectal Cancer Screening Guidelines with Family Medicine Physicians. In the new guidelines published in May 2018, ACS now recommends that starting at age 45 years, adults with an average risk of colorectal cancer undergo regular screening with either a high-sensitivity stool-based test or a structural (visual) examination, depending on patient preference and test availability. Six testing options are recommended, including FIT annually and colonoscopy every 10 years. According to the ACS, the reason for lowering the age range was based on the marked increase in colorectal cancer amongst younger adults. The ACS reported a 51% increase among those individuals under the age of 55 between 1994 and 2014.InSure ONE, a convenient at-home collection FIT, intended to detect blood in stool, is easy to use, and may improve compliance for screening programs. Unlike other FITs, InSure ONE simply requires a sample of water from the toilet bowl following a single bowel movement. Sample collection is completed in minutes using a long-handled brush and does not require the user to collect, handle, or smear fecal matter.

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione /  Modifica )

Google+ photo

Stai commentando usando il tuo account Google+. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

 
%d blogger hanno fatto clic su Mi Piace per questo: